Jeremy Sugarman, Carol Levine. Show Affiliations »
Abstract
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedClinical Trials as Topic/adverse effectsHumansResearch DesignRisk Factors
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedTGN-1412
Year: 2006 PMID: 17189020 DOI: 10.1016/S0140-6736(06)69881-4
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321